Clinical-stage biotech firm Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) was up nearly 50% in trading on Tuesday after it

      Related Articles Much like the cannabis industry, there is no standard set for what a legal psychedelics programs looks like.

      A majority of states will legalize psychedelics by 2037, according to a new analysis published in an American Medical Association

      For years, medical professionals have been treating their patients with a series of drugs and therapies with limited ongoing success.

      Congressional lawmakers didn’t include marijuana provisions in a must-pass defense bill that was released on Tuesday, but a joint explanatory

      While it is still unknown whether insurance will pay for psychedelics-based mental health treatment, there is some evidence that providers

      The future of psychedelics as an industry is dependent on the research being done today. But most psychedelics clinical trials

      Table of Contents My mom has stories galore about smoking PCP in Central Park or taking acid while horseback riding

      Chemically synthesized psilocybin has a long history, and there has been a lot written and discussed about the differences and